| Year |
Citation |
Score |
| 2009 |
Oh HS, Pathak HB, Goodfellow IG, Arnold JJ, Cameron CE. Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants. Journal of Virology. 83: 9370-87. PMID 19587035 DOI: 10.1128/Jvi.02076-08 |
0.683 |
|
| 2008 |
Pathak HB, Oh HS, Goodfellow IG, Arnold JJ, Cameron CE. Picornavirus genome replication: roles of precursor proteins and rate-limiting steps in oriI-dependent VPg uridylylation. The Journal of Biological Chemistry. 283: 30677-88. PMID 18779320 DOI: 10.1074/Jbc.M806101200 |
0.663 |
|
| 2008 |
Shen M, Reitman ZJ, Zhao Y, Moustafa I, Wang Q, Arnold JJ, Pathak HB, Cameron CE. Picornavirus genome replication. Identification of the surface of the poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg uridylylation and construction of a structural model for the PV 3C2-3Dpol complex. The Journal of Biological Chemistry. 283: 875-88. PMID 17993457 DOI: 10.1074/Jbc.M707907200 |
0.679 |
|
| 2007 |
Shen M, Wang Q, Yang Y, Pathak HB, Arnold JJ, Castro C, Lemon SM, Cameron CE. Human rhinovirus type 14 gain-of-function mutants for oriI utilization define residues of 3C(D) and 3Dpol that contribute to assembly and stability of the picornavirus VPg uridylylation complex. Journal of Virology. 81: 12485-95. PMID 17855535 DOI: 10.1128/Jvi.00972-07 |
0.606 |
|
| 2007 |
Pathak HB, Arnold JJ, Wiegand PN, Hargittai MR, Cameron CE. Picornavirus genome replication: assembly and organization of the VPg uridylylation ribonucleoprotein (initiation) complex. The Journal of Biological Chemistry. 282: 16202-13. PMID 17392285 DOI: 10.1074/Jbc.M610608200 |
0.666 |
|
| 2007 |
Marcotte LL, Wass AB, Gohara DW, Pathak HB, Arnold JJ, Filman DJ, Cameron CE, Hogle JM. Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase. Journal of Virology. 81: 3583-96. PMID 17251299 DOI: 10.1128/Jvi.02306-06 |
0.63 |
|
| 2005 |
Franco D, Pathak HB, Cameron CE, Rombaut B, Wimmer E, Paul AV. Stimulation of poliovirus RNA synthesis and virus maturation in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro. Virology Journal. 2: 86. PMID 16300678 DOI: 10.1186/1743-422X-2-86 |
0.669 |
|
| 2005 |
Franco D, Pathak HB, Cameron CE, Rombaut B, Wimmer E, Paul AV. Stimulation of poliovirus synthesis in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro. Journal of Virology. 79: 6358-67. PMID 15858019 DOI: 10.1128/Jvi.79.10.6358-6367.2005 |
0.693 |
|
| 2002 |
Pathak HB, Ghosh SK, Roberts AW, Sharma SD, Yoder JD, Arnold JJ, Gohara DW, Barton DJ, Paul AV, Cameron CE. Structure-function relationships of the RNA-dependent RNA polymerase from poliovirus (3Dpol). A surface of the primary oligomerization domain functions in capsid precursor processing and VPg uridylylation. The Journal of Biological Chemistry. 277: 31551-62. PMID 12077141 DOI: 10.1074/Jbc.M204408200 |
0.667 |
|
| 2001 |
Wei L, Huhn JS, Mory A, Pathak HB, Sosnovtsev SV, Green KY, Cameron CE. Proteinase-polymerase precursor as the active form of feline calicivirus RNA-dependent RNA polymerase. Journal of Virology. 75: 1211-9. PMID 11152494 DOI: 10.1128/Jvi.75.3.1211-1219.2001 |
0.612 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Hu M, Brown V, Jackson JM, Wijerathne H, Pathak H, Koestler DC, Nissen E, Hupert ML, Muller R, Godwin AK, Witek MA, Soper SA. Assessing Breast Cancer Molecular Subtypes Using Extracellular Vesicles' mRNA. Analytical Chemistry. PMID 37071799 DOI: 10.1021/acs.analchem.3c00624 |
0.24 |
|
| 2022 |
Gamage SST, Pahattuge TN, Wijerathne H, Childers K, Vaidyanathan S, Athapattu US, Zhang L, Zhao Z, Hupert ML, Muller RM, Muller-Cohn J, Dickerson J, Dufek D, Geisbrecht BV, Pathak H, et al. Microfluidic affinity selection of active SARS-CoV-2 virus particles. Science Advances. 8: eabn9665. PMID 36170362 DOI: 10.1126/sciadv.abn9665 |
0.191 |
|
| 2023 |
Zha D, Rayamajhi S, Sipes J, Russo A, Pathak HB, Li K, Sardiu ME, Bantis LE, Mitra A, Puri RV, Trinidad CV, Cain BP, Isenberg BC, Coppeta J, MacLaughlan S, et al. Proteomic Profiling of Fallopian Tube-Derived Extracellular Vesicles Using a Microfluidic Tissue-on-Chip System. Bioengineering (Basel, Switzerland). 10. PMID 37106610 DOI: 10.3390/bioengineering10040423 |
0.166 |
|
| 2012 |
Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. Plos One. 7: e47086. PMID 23056589 DOI: 10.1371/Journal.Pone.0047086 |
0.152 |
|
| 2014 |
Do TV, Xiao F, Bickel LE, Klein-Szanto AJ, Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, Litwin S, Golemis EA, Schilder RJ, Godwin AK, Connolly DC. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion. Oncogene. 33: 539-49. PMID 23334327 DOI: 10.1038/Onc.2012.632 |
0.146 |
|
| 2008 |
Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, Testa JR, Eisenberg B, von Mehren M, Godwin AK. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proceedings of the National Academy of Sciences of the United States of America. 105: 8387-92. PMID 18550829 DOI: 10.1073/pnas.0803383105 |
0.139 |
|
| 2023 |
Trinidad CV, Pathak HB, Cheng S, Tzeng SC, Madan R, Sardiu ME, Bantis LE, Deighan C, Jewell A, Rayamajhi S, Zeng Y, Godwin AK. Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer. Scientific Reports. 13: 18341. PMID 37884576 DOI: 10.1038/s41598-023-44050-5 |
0.131 |
|
| 2023 |
Trinidad C, Pathak H, Cheng S, Tzeng SC, Madan R, Sardiu M, Bantis L, Deighan C, Jewell A, Zeng Y, Godwin A. Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer. Research Square. PMID 37205573 DOI: 10.21203/rs.3.rs-2814022/v1 |
0.13 |
|
| 2020 |
Braun MW, Abdelhakim H, Li M, Hyter S, Pessetto Z, Koestler DC, Pathak HB, Dunavin N, Godwin AK. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer. Journal For Immunotherapy of Cancer. 8. PMID 33037114 DOI: 10.1136/jitc-2020-000706 |
0.121 |
|
| 2024 |
Mamtani H, Pathak H, Sakhardande K, Gowda GS, Muliyala KP, Philip M, Moirangthem S, Reddi VSK, Varambally S. Suicide attempts in schizophrenia - A large retrospective cohort study from a tertiary care psychiatry centre in India. Asian Journal of Psychiatry. 96: 104053. PMID 38678797 DOI: 10.1016/j.ajp.2024.104053 |
0.12 |
|
| 2024 |
Pathak H, Bagali K, Nayok SB, Nichenametla S, Shah V, Shroff M, Sreeraj VS, Venkatasubramanian G. Beyond conventional: Feasibility of accelerated tACS in clozapine-resistant schizophrenia - A case report. Asian Journal of Psychiatry. 95: 104029. PMID 38547574 DOI: 10.1016/j.ajp.2024.104029 |
0.12 |
|
| 2020 |
Park GY, Pathak HB, Godwin AK, Kwon Y. Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation. Cellular Oncology (Dordrecht). PMID 32910411 DOI: 10.1007/s13402-020-00554-0 |
0.113 |
|
| 2018 |
Hyter S, Hirst J, Pathak H, Pessetto ZY, Koestler DC, Raghavan R, Pei D, Godwin AK. Developing a genetic signature to predict drug response in ovarian cancer. Oncotarget. 9: 14828-14848. PMID 29599910 DOI: 10.18632/oncotarget.23663 |
0.11 |
|
| 2023 |
Turaga SM, Vishwakarma V, Hembruff SL, Gibbs BK, Sabu P, Puri RV, Pathak HB, Samuel G, Godwin AK. Inducing Mitotic Catastrophe as a Therapeutic Approach to Improve Outcomes in Ewing Sarcoma. Cancers. 15. PMID 37894278 DOI: 10.3390/cancers15204911 |
0.108 |
|
| 2015 |
Pathak HB, Zhou Y, Sethi G, Hirst J, Schilder RJ, Golemis EA, Godwin AK. A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer. Plos One. 10: e0144126. PMID 26637171 DOI: 10.1371/Journal.Pone.0144126 |
0.105 |
|
| 2018 |
Hirst J, Pathak HB, Hyter S, Pessetto ZY, Ly T, Graw S, Koestler DC, Krieg AJ, Roby KF, Godwin AK. Licofelone enhances the efficacy of paclitaxel in ovarian cancer by reversing drug resistance and tumor stem-like properties. Cancer Research. PMID 29891506 DOI: 10.1158/0008-5472.CAN-17-3993 |
0.102 |
|
| 2012 |
Ratushny V, Pathak HB, Beeharry N, Tikhmyanova N, Xiao F, Li T, Litwin S, Connolly DC, Yen TJ, Weiner LM, Godwin AK, Golemis EA. Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death. Oncogene. 31: 1217-27. PMID 21785464 DOI: 10.1038/Onc.2011.314 |
0.1 |
|
| 2024 |
Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Pathak H, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243 |
0.095 |
|
| 2014 |
Sethi G, Kwon Y, Burkhalter RJ, Pathak HB, Madan R, McHugh S, Atay S, Murthy S, Tawfik OW, Godwin AK. PTN signaling: Components and mechanistic insights in human ovarian cancer. Molecular Carcinogenesis. PMID 25418856 DOI: 10.1002/Mc.22249 |
0.089 |
|
| 2022 |
Crow J, Samuel G, Farrow E, Gibson M, Johnston J, Guest E, Miller N, Pei D, Koestler D, Pathak H, Liang X, Mangels C, Godwin AK. MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation. Biomarker Insights. 17: 11772719221132693. PMID 36341281 DOI: 10.1177/11772719221132693 |
0.084 |
|
| 2016 |
Zook P, Pathak HB, Belinsky M, Gersz L, Devarajan K, Zhou Y, Godwin AK, von Mehren M, Rink LA. Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27370604 DOI: 10.1158/1078-0432.Ccr-16-0529 |
0.081 |
|
| 2021 |
Gupta VG, Hirst J, Petersen S, Roby KF, Kusch M, Zhou H, Clive ML, Jewell A, Pathak HB, Godwin AK, Wilson AJ, Crispens MA, Cybulla E, Vindigni A, Fuh KC, et al. Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer. Gynecologic Oncology. PMID 33867143 DOI: 10.1016/j.ygyno.2021.04.015 |
0.081 |
|
| 2015 |
Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, ... ... Pathak H, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985 |
0.077 |
|
| 2023 |
Rodler E, Sharma P, Barlow WE, Gralow JR, Puhalla SL, Anders CK, Goldstein L, Tripathy D, Brown-Glaberman UA, Huynh TT, Szyarto CS, Godwin AK, Pathak HB, Swisher EM, Radke MR, et al. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet. Oncology. PMID 36623515 DOI: 10.1016/S1470-2045(22)00739-2 |
0.075 |
|
| 2012 |
Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Pathak H, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229 |
0.074 |
|
| 2024 |
Saeed A, Park R, Pathak H, Al-Bzour AN, Dai J, Phadnis M, Al-Rajabi R, Kasi A, Baranda J, Sun W, Williamson S, Chiu YC, Osmanbeyoglu HU, Madan R, Abushukair H, et al. Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature Communications. 15: 1533. PMID 38378868 DOI: 10.1038/s41467-024-45960-2 |
0.072 |
|
| 2020 |
Sharma P, Rodler E, Barlow WE, Gralow J, Huggins-Puhalla SL, Anders CK, Goldstein LJ, Brown-Glaberman UA, Huynh T, Szyarto CS, Godwin AK, Pathak HB, Swisher EM, Radke MR, Timms KM, et al. Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416). Journal of Clinical Oncology. 38: 1001-1001. DOI: 10.1200/jco.2020.38.15_suppl.1001 |
0.071 |
|
| 2022 |
Gokulakrishnan K, Nikhil J, Vs S, Holla B, Thirumoorthy C, Sandhya N, Nichenametla S, Pathak H, Shivakumar V, Debnath M, Venkatasubramanian G, Varambally S. Altered Intestinal Permeability Biomarkers in Schizophrenia: A Possible Link with Subclinical Inflammation. Annals of Neurosciences. 29: 151-158. PMID 36419512 DOI: 10.1177/09727531221108849 |
0.069 |
|
| 2019 |
Sharma P, Barlow WE, Godwin AK, Parkes EE, Knight LA, Walker SM, Kennedy RD, Harkin DP, Logan GE, Steele CJ, Lambe SM, Badve S, Gökmen-Polar Y, Pathak HB, Isakova K, et al. Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900693. PMID 31657982 DOI: 10.1200/Jco.19.00693 |
0.067 |
|
| 2017 |
Sharma P, Barlow WE, Godwin AK, Pathak H, Isakova K, Williams D, Timms KM, Hartman AR, Wenstrup RJ, Linden HM, Tripathy D, Hortobagyi GN, Hayes DF. Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with doxorubicin-based adjuvant chemotherapy (SWOG S9313). Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29293876 DOI: 10.1093/annonc/mdx821 |
0.065 |
|
| 2021 |
Li M, Soder R, Abhyankar S, Abdelhakim H, Braun MW, Trinidad CV, Pathak HB, Pessetto Z, Deighan C, Ganguly S, Dawn B, McGuirk J, Dunavin N, Godwin AK. WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1. Journal of Extracellular Vesicles. 10: e12067. PMID 33598108 DOI: 10.1002/jev2.12067 |
0.06 |
|
| 2023 |
Stecklein SR, Kimler BF, Yoder R, Schwensen K, Staley JM, Khan QJ, O'Dea AP, Nye LE, Elia M, Heldstab J, Home T, Hyter S, Isakova K, Pathak HB, Godwin AK, et al. ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. Npj Breast Cancer. 9: 10. PMID 36878909 DOI: 10.1038/s41523-023-00512-7 |
0.059 |
|
| 2013 |
Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, ... ... Pathak H, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics. 45: 392-8, 398e1-2. PMID 23535733 DOI: 10.1038/Ng.2561 |
0.054 |
|
| 2023 |
Pathak H, Sreeraj VS, Venkatasubramanian G. Transcranial Alternating Current Stimulation (tACS) and Its Role in Schizophrenia: A Scoping Review. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 21: 634-649. PMID 37859437 DOI: 10.9758/cpn.22.1042 |
0.054 |
|
| 2012 |
Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, ... ... Pathak H, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human Mutation. 33: 690-702. PMID 22253144 DOI: 10.1002/Humu.22025 |
0.052 |
|
| 2011 |
Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, ... ... Pathak H, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature Genetics. 43: 1210-4. PMID 22037553 DOI: 10.1038/Ng.985 |
0.051 |
|
| 2023 |
Freed IM, Kasi A, Fateru O, Hu M, Gonzalez P, Weatherington N, Pathak H, Hyter S, Sun W, Al-Rajabi R, Baranda J, Hupert ML, Chalise P, Godwin AK, A Witek M, et al. Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. Cells. 12. PMID 37759489 DOI: 10.3390/cells12182266 |
0.049 |
|
| 2024 |
Uppinkudru C, Pathak H, Kumar K R, S B, Bagali K, Pantoji M, Ezhumalai N, Parlikar R, Shah V, Balachander S, Sreeraj VS, Mehta UM, Sinha P, Arumugham SS, Venkatasubramanian G, et al. Development, validation and clinical utility of short-term adverse-effects of electroconvulsive therapy (SAVE) checklist. Psychiatry Research. 335: 115839. PMID 38503006 DOI: 10.1016/j.psychres.2024.115839 |
0.047 |
|
| 2023 |
Myers JS, Parks AC, Mahnken JD, Young KJ, Pathak HB, Puri RV, Unrein A, Switzer P, Abdulateef Y, Sullivan S, Walker JF, Streeter D, Burns JM. First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function. Cancers. 15. PMID 36900405 DOI: 10.3390/cancers15051615 |
0.047 |
|
| 2012 |
Schilder RJ, Brady WE, Lankes HA, Fiorica JV, Shahin MS, Zhou XC, Mannel RS, Pathak HB, Hu W, Alpaugh RK, Sood AK, Godwin AK. Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology. 127: 70-4. PMID 22710075 DOI: 10.1016/j.ygyno.2012.06.009 |
0.046 |
|
| 2012 |
Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomäki K, Amiano P, Apicella C, ... ... Pathak H, et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human Molecular Genetics. 21: 5373-84. PMID 22976474 DOI: 10.1093/Hmg/Dds381 |
0.046 |
|
| 2009 |
Schilder RJ, Pathak HB, Lokshin AE, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecologic Oncology. 113: 21-7. PMID 19162309 DOI: 10.1200/Jco.2007.25.18_Suppl.5577 |
0.046 |
|
| 2011 |
Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H, ... ... Pathak H, et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Research. 71: 6240-9. PMID 21844186 DOI: 10.1158/0008-5472.Can-11-1266 |
0.045 |
|
| 2021 |
Sharma P, Abramson VG, O'Dea AP, Nye L, Mayer IA, Pathak HB, Hoffmann M, Stecklein SR, Elia M, Lewis S, Scott J, De Jong JA, Wang YY, Yoder R, Schwensen K, et al. Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33602685 DOI: 10.1158/1078-0432.CCR-20-4879 |
0.044 |
|
| 2022 |
Chugh RM, Bhanja P, Olea XD, Tao F, Schroeder K, Zitter R, Arora T, Pathak H, Kimler BF, Godwin AK, Perry JM, Saha S. Human Peripheral Blood Mononucleocyte Derived Myeloid Committed Progenitor Cells Mitigate H-ARS by Exosomal Paracrine Signal. International Journal of Molecular Sciences. 23. PMID 35628308 DOI: 10.3390/ijms23105498 |
0.044 |
|
| 2021 |
Nayok SB, Pathak H, Suhas S, Thimmashetty VH, Shivaprakash P, Madhu Sudhan RM, Sreeraj VS, Narayanaswamy JC, Venkatasubramanian G. Concurrent conventional & high-definition transcranial direct current stimulation for treatment of schizophrenia with co-morbid obsessive-compulsive disorder: A case report. Brain Stimulation. 14: 1483-1485. PMID 34597856 DOI: 10.1016/j.brs.2021.09.010 |
0.042 |
|
| 2012 |
Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, Nevanlinna H, Greco D, Aittomäki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, Wang-Gohrke S, ... ... Pathak HB, et al. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Research. 72: 1795-803. PMID 22331459 DOI: 10.1158/0008-5472.Can-11-3364 |
0.04 |
|
| 2011 |
Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 12: 169-80. PMID 21617380 DOI: 10.4161/Cbt.12.3.16260 |
0.039 |
|
| 2022 |
Sakhardande KA, Pathak H, Mahadevan J, Muliyala KP, Moirangthem S, Reddi VSK. Concurrent catatonia and COVID-19 infection - An experiential account of challenges and management of cases from a tertiary care psychiatric hospital in India. Asian Journal of Psychiatry. 69: 103004. PMID 35016069 DOI: 10.1016/j.ajp.2022.103004 |
0.039 |
|
| 2022 |
Singh A, Kumar V, Pathak H, Jacob AA, Venkatasubramanian G, Varambally S, Rao NP. Effect of antipsychotic dose reduction on cognitive function in schizophrenia. Psychiatry Research. 308: 114383. PMID 34999291 DOI: 10.1016/j.psychres.2021.114383 |
0.039 |
|
| 2016 |
Raghavan R, Hyter S, Pathak HB, Godwin AK, Konecny G, Wang C, Goode EL, Fridley BL. Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer. Bmc Genomics. 17: 811. PMID 27756228 DOI: 10.1186/S12864-016-3149-5 |
0.037 |
|
| 2022 |
Khan QJ, Bivona CR, Martin GA, Zhang J, Liu B, He J, Li KH, Nelson M, Williamson S, Doolittle GC, Sun W, Mudaranthakam DP, Streeter NR, McGuirk JP, Al-Rajabi R, ... ... Pathak H, et al. Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant. Jama Oncology. PMID 35446353 DOI: 10.1001/jamaoncol.2022.0752 |
0.035 |
|
| 2022 |
Myers J, Pathak HB, He J, Ghosh A, Puri RV, Asakura Y, Miyashita M. Combined Exercise and Game-Based Cognitive Training Intervention: Correlative Pilot Study of Neurotrophic and Inflammatory Biomarkers for Women With Breast Cancer. Cancer Nursing. PMID 36542098 DOI: 10.1097/NCC.0000000000001175 |
0.034 |
|
| 2022 |
Khan QJ, Bivona CR, Liu B, Nelson M, Martin GA, Mushtaq MU, Sharma P, Streeter NR, Hoffmann M, Doolittle GC, Zhong C, Mitchell L, Li KH, Pessetto ZY, Ghosh A, ... Pathak HB, et al. Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients. Bone Marrow Transplantation. PMID 35388117 DOI: 10.1038/s41409-022-01653-2 |
0.032 |
|
| 2021 |
Dimachkie MD, Bechtel MD, Robertson HL, Michel C, Lee EK, Sullivan DK, Chalise P, Thrasher JB, Parker WP, Godwin AK, Pathak HB, DiGiovanni J, Shivappa N, Hébert JR, Hamilton-Reeves JM. Exploration of biomarkers from a pilot weight management study for men undergoing radical prostatectomy. Urologic Oncology. PMID 33563536 DOI: 10.1016/j.urolonc.2021.01.010 |
0.031 |
|
| 2018 |
Sharma P, Abramson VG, O'Dea A, Pathak HB, Pessetto ZY, Wang YY, Finke K, Hoffmann MS, Elia M, Lewis S, Scott J, De Jong J, Urban J, Heldstab J, LaFaver S, et al. Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer. Journal of Clinical Oncology. 36: 1018-1018. DOI: 10.1200/JCO.2018.36.15_SUPPL.1018 |
0.024 |
|
| 2019 |
Fang CY, Egleston BL, Byrne C, Bohr GS, Pathak HB, Godwin AK, Siu PT, Tseng M. Inflammation and breast density among female Chinese immigrants: exploring variations across neighborhoods. Cancer Causes & Control : Ccc. PMID 31392546 DOI: 10.1007/S10552-019-01206-X |
0.021 |
|
| 2014 |
Fang CY, Ross EA, Pathak HB, Godwin AK, Tseng M. Acculturative stress and inflammation among Chinese immigrant women. Psychosomatic Medicine. 76: 320-6. PMID 24846001 DOI: 10.1097/PSY.0000000000000065 |
0.021 |
|
| 2022 |
Mamtani H, Pathak H, Sakhardande KA, Gowda GS, Muliyala KP, Moirangthem S, Reddi VSK, Varambally S. Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia? Schizophrenia Research. 243: 203-205. PMID 35398726 DOI: 10.1016/j.schres.2022.03.010 |
0.018 |
|
| 2023 |
Kanakaraj L, Nayok SB, Bose A, Pathak H, Bagali KB, Sreeraj VS, Shivakumar V, Venkatasubramanian G. Extended accelerated tDCS and correction of prediction error signalling in Schizophrenia with atypical hallucinations: A case report. Asian Journal of Psychiatry. 88: 103730. PMID 37625328 DOI: 10.1016/j.ajp.2023.103730 |
0.015 |
|
| 2022 |
Pathak H, Nayok SB, Kanakaraj L, Ghanghoriya H, Sreeraj VS, Varambally S, Venkatasubramanian G. Accelerated HD-tDCS for rapid response in treatment-resistant obsessive-compulsive disorder: A case report. Brain Stimulation. 15: 1091-1092. PMID 35963542 DOI: 10.1016/j.brs.2022.08.003 |
0.014 |
|
| 2020 |
Nanjundaswamy MH, Pathak H, Chaturvedi SK. Perceived stress and anxiety during COVID-19 among psychiatry trainees. Asian Journal of Psychiatry. 54: 102282. PMID 32679530 DOI: 10.1016/j.ajp.2020.102282 |
0.01 |
|
| 2019 |
Pathak H, Damodharan D, Jayasankar P, Sreeraj VS, Venkatasubramanian G. Safety of clozapine in patient with treatment resistant schizophrenia & asymptomatic constitutional macrothrombocytopenia (Harris syndrome). Asian Journal of Psychiatry. 45: 121-122. PMID 31569026 DOI: 10.1016/j.ajp.2019.09.012 |
0.01 |
|
| Hide low-probability matches. |